StockData

Microchip Technology vs NXP Semiconductors

MCHP and NXPI side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MCHP and NXPI compare

NXP Semiconductors is the larger company, worth 1.6 times as much as Microchip Technology ($65.5B against $42.0B).

On earnings, NXP Semiconductors is cheaper: it trades at 22.2× trailing earnings, against 115× for Microchip Technology.

Microchip Technology grew revenue faster over the last twelve months (20.9% versus 8.8% for NXP Semiconductors).

NXP Semiconductors keeps more of each dollar of sales as profit, with a net margin of 22.6% compared with 9.3% at Microchip Technology.

Both pay dividends: Microchip Technology yields 2.4% and NXP Semiconductors 1.6%.

NXP Semiconductors scores higher on the StockData Score (19 against 12 for Microchip Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMCHPNXPI
Size and price
Market cap$42.0B$65.5B
Share price$77.34$259.61
Change, 1 year23.7%26.8%
Change, 5 years−9.8%15.8%
Beta (5Y)1.671.38
Employees18K32K
StockData Score
Total score1219 (better)
Valuation score04 (better)
Growth score3 (better)1
Performance score26 (better)
Health score44
Dividend score34 (better)
Valuation
P/E115×22.2× (better)
P/S8.2×5.0× (better)
P/B6.5×5.7× (better)
EV/EBITDA32.0×14.7× (better)
P/FCF37.8×23.3× (better)
FCF yield2.6%4.3% (better)
Fair value$33.00$335.91
Margin of safety−134%22.7% (better)
Growth
Revenue growth (TTM)20.9% (better)8.8%
Revenue growth, 5Y average−2.8%7.3% (better)
Net income growth (TTM)–38.5%
EPS growth (TTM)–39.7%
EPS growth, 5Y average−19.5%113% (better)
Profitability
Gross margin60.2% (better)56.0%
Operating margin15.5%32.0% (better)
Net margin9.3%22.6% (better)
FCF margin21.7% (better)21.3%
Return on equity7.2%28.4% (better)
Return on invested capital5.6%18.3% (better)
Financial health
Debt / equity0.83 (better)0.96
Net debt / EBITDA3.461.55 (better)
Interest coverage3.7×8.9× (better)
Current ratio1.922.04 (better)
Altman Z-score4.28 (better)3.83
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield2.4% (better)1.6%
Payout ratio206%34.4%
Years of dividend growth17 (better)0
Dividend growth, 5Y average19.5%22.0% (better)
Buyback yield−0.15%0.91% (better)
Shareholder yield2.2%2.5% (better)
Ownership
Held by institutions100%95.4%
Held by insiders2.0%0.14%
Insider net buying, 12 months−$71.1M−$10.3M (better)
Superinvestors holding2 (better)1
Short interest, % of float–2.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.